Home524816 • BOM
add
Natco Pharma Ltd
Previous close
₹875.25
Day range
₹875.25 - ₹885.90
Year range
₹660.05 - ₹1,638.35
Market cap
157.07B INR
Avg Volume
83.00K
P/E ratio
9.24
Dividend yield
0.57%
Primary exchange
NSE
Market news
.DJI
0.078%
0.75%
0.29%
0.51%
Financials
Income Statement
Revenue
Net income
(INR) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 13.29B | -2.47% |
Operating expense | 5.82B | 38.13% |
Net income | 4.81B | -28.09% |
Net profit margin | 36.17 | -26.27% |
Earnings per share | 26.84 | -28.08% |
EBITDA | 5.72B | -29.13% |
Effective tax rate | 16.02% | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 24.97B | 35.02% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 76.12B | — |
Shares outstanding | 179.10M | — |
Price to book | 2.06 | — |
Return on assets | — | — |
Return on capital | 16.26% | — |
Cash Flow
Net change in cash
(INR) | Jun 2025info | Y/Y change |
---|---|---|
Net income | 4.81B | -28.09% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations, active pharmaceutical ingredients and agrochemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs at affordable prices. Wikipedia
Founded
1981
Headquarters
Website
Employees
4,016